Pulmonx (LUNG) Net Cash Flow (2019 - 2025)

Pulmonx (LUNG) has 7 years of Net Cash Flow data on file, last reported at $700000.0 in Q3 2025.

• Net Cash Flow for Q3 2025 came in at $700000.0, up 6900.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.0 million (up 147.1% YoY), and the FY2024 annual result was -$12.7 million, up 30.26% from the prior year.
• Net Cash Flow eased to $700000.0 in Q3 2025 per LUNG's latest filing, from $1.5 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $8.7 million in Q1 2023 and troughed at -$39.7 million in Q4 2021.
• A 5-year average of -$8.2 million and a median of -$8.6 million in 2023 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2021 and 2025: Net Cash Flow tumbled 1550.26% in 2021, then soared 6900.0% in 2025.
• A 5-year view of Net Cash Flow shows it stood at -$39.7 million in 2021, then jumped by 73.62% to -$10.5 million in 2022, then decreased by 6.42% to -$11.1 million in 2023, then surged by 166.37% to $7.4 million in 2024, then tumbled by 90.53% to $700000.0 in 2025.
• Business Quant data shows LUNG's Net Cash Flow at $700000.0 in Q3 2025, $1.5 million in Q2 2025, and $3.8 million in Q1 2025.